154 related articles for article (PubMed ID: 24766983)
1. Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).
Rosenberg MA; Maziarz M; Tan AY; Glazer NL; Zieman SJ; Kizer JR; Ix JH; Djousse L; Siscovick DS; Heckbert SR; Mukamal KJ
Am Heart J; 2014 May; 167(5):723-8.e2. PubMed ID: 24766983
[TBL] [Abstract][Full Text] [Related]
2. Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Heckbert SR; Alonso A; Gross MD; Ix JH; Kizer JR; Tracy RP; Kronmal R; Jacobs DR
Circ Arrhythm Electrophysiol; 2018 Oct; 11(10):e006557. PubMed ID: 30354407
[TBL] [Abstract][Full Text] [Related]
3. Galectin 3 and incident atrial fibrillation in the community.
Ho JE; Yin X; Levy D; Vasan RS; Magnani JW; Ellinor PT; McManus DD; Lubitz SA; Larson MG; Benjamin EJ
Am Heart J; 2014 May; 167(5):729-34.e1. PubMed ID: 24766984
[TBL] [Abstract][Full Text] [Related]
4. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
[TBL] [Abstract][Full Text] [Related]
5. Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion.
Kawamura M; Munetsugu Y; Kawasaki S; Onishi K; Onuma Y; Kikuchi M; Tanno K; Kobayashi Y
Europace; 2012 Dec; 14(12):1719-25. PubMed ID: 22622138
[TBL] [Abstract][Full Text] [Related]
6. Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome.
Richter B; Gwechenberger M; Socas A; Zorn G; Albinni S; Marx M; Wolf F; Bergler-Klein J; Loewe C; Bieglmayer C; Binder T; Wojta J; Gössinger HD
Int J Cardiol; 2011 Oct; 152(2):231-6. PubMed ID: 20692054
[TBL] [Abstract][Full Text] [Related]
7. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation.
Swartz MF; Fink GW; Sarwar MF; Hicks GL; Yu Y; Hu R; Lutz CJ; Taffet SM; Jalife J
J Am Coll Cardiol; 2012 Oct; 60(18):1799-806. PubMed ID: 23040566
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.
Zhao F; Zhang S; Chen Y; Gu W; Ni B; Shao Y; Wu Y; Qin J
BMC Cardiovasc Disord; 2014 Nov; 14():167. PubMed ID: 25422138
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study.
Agarwal I; Glazer NL; Barasch E; Biggs ML; Djoussé L; Fitzpatrick AL; Gottdiener JS; Ix JH; Kizer JR; Rimm EB; Siscovick DS; Tracy RP; Zieman SJ; Mukamal KJ
Am J Epidemiol; 2014 Jun; 179(11):1331-9. PubMed ID: 24771724
[TBL] [Abstract][Full Text] [Related]
10. Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults.
Hussein AA; Bartz TM; Gottdiener JS; Sotoodehnia N; Heckbert SR; Lloyd-Jones D; Kizer JR; Christenson R; Wazni O; deFilippi C
Heart Rhythm; 2015 May; 12(5):879-85. PubMed ID: 25602173
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis-related biomarkers and large and small vessel disease: the Cardiovascular Health Study.
Agarwal I; Arnold A; Glazer NL; Barasch E; Djousse L; Fitzpatrick AL; Gottdiener JS; Ix JH; Jensen RA; Kizer JR; Rimm EB; Siscovick DS; Tracy RP; Wong TY; Mukamal KJ
Atherosclerosis; 2015 Apr; 239(2):539-46. PubMed ID: 25725316
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome.
Ionin VA; Baranova EI; Zaslavskaya EL; Petrishcheva EY; Morozov AN; Shlyakhto EV
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784491
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.
Agarwal I; Glazer NL; Barasch E; Biggs ML; Djousse L; Fitzpatrick AL; Gottdiener JS; Ix JH; Kizer JR; Rimm EB; Sicovick DS; Tracy RP; Mukamal KJ
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):583-9. PubMed ID: 24963008
[TBL] [Abstract][Full Text] [Related]
14. Fibrosis markers, hip fracture risk, and bone density in older adults.
Barzilay JI; Bůžková P; Kizer JR; Djoussé L; Ix JH; Fink HA; Siscovick DS; Cauley JA; Mukamal KJ
Osteoporos Int; 2016 Feb; 27(2):815-20. PubMed ID: 26267013
[TBL] [Abstract][Full Text] [Related]
15. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K
J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936
[TBL] [Abstract][Full Text] [Related]
16. Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.
Sonmez O; Ertem FU; Vatankulu MA; Erdogan E; Tasal A; Kucukbuzcu S; Goktekin O
Med Sci Monit; 2014 Mar; 20():463-70. PubMed ID: 24651058
[TBL] [Abstract][Full Text] [Related]
17. Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation.
Kawamura M; Ito H; Onuki T; Miyoshi F; Watanabe N; Asano T; Tanno K; Kobayashi Y
J Cardiovasc Pharmacol; 2010 May; 55(5):511-7. PubMed ID: 20164787
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).
Mathew JS; Sachs MC; Katz R; Patton KK; Heckbert SR; Hoofnagle AN; Alonso A; Chonchol M; Deo R; Ix JH; Siscovick DS; Kestenbaum B; de Boer IH
Circulation; 2014 Jul; 130(4):298-307. PubMed ID: 24920722
[TBL] [Abstract][Full Text] [Related]
19. Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study.
Begg GA; Lip GY; Plein S; Tayebjee MH
Clin Biochem; 2017 Jan; 50(1-2):11-15. PubMed ID: 27622867
[TBL] [Abstract][Full Text] [Related]
20. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.
Macheret F; Bartz TM; Djousse L; Ix JH; Mukamal KJ; Zieman SJ; Siscovick DS; Tracy RP; Heckbert SR; Psaty BM; Kizer JR
Heart; 2015 Sep; 101(17):1368-74. PubMed ID: 25855796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
